18.05
price up icon3.32%   0.58
after-market アフターアワーズ: 18.82 0.77 +4.27%
loading
前日終値:
$17.47
開ける:
$17.33
24時間の取引高:
1.38M
Relative Volume:
1.50
時価総額:
$1.92B
収益:
$247.00M
当期純損益:
$-249.00M
株価収益率:
-5.8414
EPS:
-3.09
ネットキャッシュフロー:
$-267.00M
1週間 パフォーマンス:
+15.56%
1か月 パフォーマンス:
+45.68%
6か月 パフォーマンス:
+134.11%
1年 パフォーマンス:
+6.36%
1日の値動き範囲:
Value
$17.02
$18.42
1週間の範囲:
Value
$15.38
$18.42
52週間の値動き範囲:
Value
$6.50
$18.98

Arcus Biosciences Inc Stock (RCUS) Company Profile

Name
名前
Arcus Biosciences Inc
Name
セクター
Healthcare (1139)
Name
電話
(510) 694-6200
Name
住所
3928 POINT EDEN WAY, HAYWARD, CA
Name
職員
674
Name
Twitter
@arcusbio
Name
次回の収益日
2024-12-06
Name
最新のSEC提出書
Name
RCUS's Discussions on Twitter

RCUS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RCUS
Arcus Biosciences Inc
18.05 1.86B 247.00M -249.00M -267.00M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.27 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
474.00 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.34 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
834.75 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.31 35.49B 398.11M -1.03B -868.57M -5.7032

Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-26 アップグレード H.C. Wainwright Neutral → Buy
2024-10-21 開始されました H.C. Wainwright Neutral
2024-10-08 開始されました Wells Fargo Overweight
2022-11-18 開始されました BofA Securities Neutral
2022-10-11 開始されました Morgan Stanley Overweight
2021-10-15 再開されました BTIG Research Buy
2020-11-24 開始されました Berenberg Buy
2020-11-23 開始されました Evercore ISI Outperform
2020-04-03 開始されました Cantor Fitzgerald Overweight
2020-03-04 開始されました Barclays Overweight
2019-11-12 開始されました SunTrust Buy
2019-09-27 開始されました Mizuho Buy
2019-05-24 再開されました Citigroup Buy
2018-10-09 開始されました Wedbush Outperform
2018-04-09 開始されました Citigroup Buy
2018-04-09 開始されました Goldman Neutral
2018-04-09 開始されました Leerink Partners Outperform
すべてを表示

Arcus Biosciences Inc (RCUS) 最新ニュース

pulisher
04:17 AM

Using AI based signals to follow Arcus Biosciences Inc.Weekly Volume Report & Entry Point Confirmation Signals - newser.com

04:17 AM
pulisher
03:56 AM

Analyzing recovery setups for Arcus Biosciences Inc. investors2025 Valuation Update & Advanced Technical Analysis Signals - newser.com

03:56 AM
pulisher
07:37 AM

Arcus Biosciences Inc. recovery potential after sell offMarket Performance Recap & Long-Term Safe Return Strategies - newser.com

07:37 AM
pulisher
03:55 AM

Why Arcus Biosciences Inc. stock appears on watchlistsTrade Entry Report & Consistent Profit Alerts - newser.com

03:55 AM
pulisher
02:28 AM

Is Arcus Biosciences Inc. stock safe for risk averse investorsQuarterly Market Review & Fast Gaining Stock Reports - newser.com

02:28 AM
pulisher
Oct 20, 2025

Should you hold or exit Arcus Biosciences Inc. nowEarnings Overview Report & Technical Pattern Based Signals - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is this a good reentry point in Arcus Biosciences Inc.July 2025 Highlights & Entry Point Confirmation Signals - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

How moving averages guide Arcus Biosciences Inc. tradingJuly 2025 WrapUp & Daily Volume Surge Signals - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

RCUS: Wells Fargo Raises Price Target on Arcus Biosciences to $2 - GuruFocus

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 09:03:52 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Applying sector rotation models to Arcus Biosciences Inc.Market Trend Summary & Daily Technical Forecast Reports - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 00:14:27 - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Taiho Exercises Option for Casdatifan Development with Arcus (RC - GuruFocus

Oct 19, 2025
pulisher
Oct 19, 2025

Will Arcus Biosciences Inc. stock benefit from sector rotationJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

Exclusive license for casdatifan in Japan & select Asian territories — Taiho exercises option from Arcus - Stock Titan

Oct 19, 2025
pulisher
Oct 19, 2025

Arcus Biosciences Hits Day High with Strong 8.19% Intraday Surge - Markets Mojo

Oct 19, 2025
pulisher
Oct 19, 2025

Arcus Biosciences Hits Day High with 13.97% Surge Amid Market Decline - Markets Mojo

Oct 19, 2025
pulisher
Oct 19, 2025

What analysts say about Arcus Biosciences Inc stockGlobal Trade Effects & Fast Growing Trading Plans - earlytimes.in

Oct 19, 2025
pulisher
Oct 19, 2025

Visual analytics tools that track Arcus Biosciences Inc. performanceWeekly Risk Report & Verified Entry Point Signals - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

Will Arcus Biosciences Inc. outperform the marketEarnings Growth Summary & Entry Point Strategy Guides - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Movement Recap: Will Arcus Biosciences Inc. stock benefit from sector rotation2025 Buyback Activity & AI Forecast Swing Trade Picks - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Can momentum traders help lift Arcus Biosciences Inc.Portfolio Profit Report & Fast Moving Stock Watchlists - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Why Arcus Biosciences Inc. stock is rated strong buyQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Growth Recap: Will Arcus Biosciences Inc. stock benefit from sector rotationJuly 2025 Institutional & Risk Managed Investment Entry Signals - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Can Arcus Biosciences Inc. stock deliver consistent EPS growthJuly 2025 Earnings & Fast Gaining Stock Reports - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 16, 2025

Arcus Biosciences: Refusing To Let The TIGIT Story Die, And Finding Potential Niches In Huge Markets - Seeking Alpha

Oct 16, 2025
pulisher
Oct 15, 2025

Arcus data throw TIGIT a lifeline: Clinical Report - biocentury.com

Oct 15, 2025
pulisher
Oct 15, 2025

What dividend safety score for Arcus Biosciences Inc. stockMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Arcus Biosciences reports Phase 2 survival data for gastric cancer study - Investing.com Australia

Oct 15, 2025
pulisher
Oct 14, 2025

Arcus’s ‘Last TIGIT Standing’ Shows Phase II Survival Benefit - Citeline News & Insights

Oct 14, 2025
pulisher
Oct 14, 2025

Arcus Biosciences Reports Promising Phase 2 Study Results - TipRanks

Oct 14, 2025
pulisher
Oct 14, 2025

Arcus Biosciences reports Phase 2 survival data for gastric cancer study By Investing.com - Investing.com South Africa

Oct 14, 2025

Arcus Biosciences Inc (RCUS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.48
price up icon 2.32%
$87.30
price up icon 1.31%
$30.13
price down icon 1.34%
$106.89
price down icon 0.98%
biotechnology ONC
$315.74
price down icon 0.90%
$165.31
price down icon 1.55%
大文字化:     |  ボリューム (24 時間):